Pred
( DrugBank: - / KEGG DRUG: - )
1 disease
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
46 | Malignant rheumatoid arthritis | 173 |
46. Malignant rheumatoid arthritis
Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228
Showing 1 to 10 of 173 trials
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT05305066 (ClinicalTrials.gov) | February 1, 202320230201 | 26/2/202220220226 | Stand UP to Rheumatoid Arthritis (SUPRA) | Innovative Trial Designs, Multi-omics and Advanced Computational Prediction to Transform Clinical Care in RA Innovative Trial Designs, Multi-omics and Advanced Computational Prediction to Transform Clinical Ca ... | Rheumatoid Arthritis | Drug: TNFi;Drug: Anti-IL6;Drug: JAKi | Marie Hudson, MD | McGill University Health Centre/Research Institute of the McGill University Health Centre;Montreal General Hospital;Lady Davis Institute McGill University Health Centre/Research Institute of the McGill University Health Centre;Montreal G ... | Recruiting | 18 Years | N/A | All | 75 | N/A | Canada |
2 | NCT05379322 (ClinicalTrials.gov) | July 202220220700 | 12/5/202220220512 | The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Patients The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Pati ... | The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Patients The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Pati ... | Rheumatoid Arthritis | Drug: Anti-TNF;Drug: JAK inhibitor | Abu Dhabi Stem Cells Center | NULL | Withdrawn | 18 Years | N/A | All | 0 | Phase 3 | United Arab Emirates |
3 | NCT05246280 (ClinicalTrials.gov) | March 2, 202220220302 | 16/12/202120211216 | Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFa Therapy Response in Moderate to Severe Active RA Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFa Therapy Response in Moderate to Severe ... | Evaluation of Tc 99m Tilmanocept Imaging for the Early Prediction of Anti-TNFa Therapy Response in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA) Evaluation of Tc 99m Tilmanocept Imaging for the Early Prediction of Anti-TNFa Therapy Response in P ... | Rheumatoid Arthritis | Drug: TC99m-tilmanocept | Navidea Biopharmaceuticals | NULL | Recruiting | 18 Years | N/A | All | 523 | Phase 3 | United States |
4 | ChiCTR2200057350 | 2022-02-2520220225 | 2022-03-0920220309 | Predictive value of TyG index and rheumatoid factor levels for cardiovascular disease risk in a population with rheumatoid arthritis Predictive value of TyG index and rheumatoid factor levels for cardiovascular disease risk in a popu ... | Predictive value of TyG index and rheumatoid factor levels for cardiovascular disease risk in a population with rheumatoid arthritis Predictive value of TyG index and rheumatoid factor levels for cardiovascular disease risk in a popu ... | rheumatoid arthritis | Gold Standard:Rheumatoid arthritis disease diagnosis is based on the ACR/EULAR criteria published in 2010 ;Index test:TyG index,rheumatoid factor; Gold Standard:Rheumatoid arthritis disease diagnosis is based on the ACR/EULAR criteria published in ... | China-Japan Friendship Hospital | NULL | Pending | 18 | 75 | Both | Target condition:150;Difficult condition:150 | China | |
5 | NCT05671627 (ClinicalTrials.gov) | February 2, 202220220202 | 19/9/202220220919 | Cortisol Circadian Rhythm in Patients With RA | An Impaired Functional Reserve of Adrenal Cortex May Associate With difficult-to Treat RA: Can a Disturbed Cortisol Circadian Rhythm Serve as a Predictor of Difficult-to-treat RA? An Impaired Functional Reserve of Adrenal Cortex May Associate With difficult-to Treat RA: Can a Dis ... | Rheumatoid Arthritis | Drug: DMARDs | National and Kapodistrian University of Athens | NULL | Recruiting | 20 Years | 80 Years | All | 50 | Greece | |
6 | NCT05651373 (ClinicalTrials.gov) | July 30, 202120210730 | 15/11/202220221115 | The Clinical Features and Pregnancy Outcomes of RA Patients | The Clinical Features and Pregnancy Outcomes of Patients With Rheumatoid Arthritis :a Prospective Cohort Study The Clinical Features and Pregnancy Outcomes of Patients With Rheumatoid Arthritis :a Prospective Co ... | Rheumatoid Arthritis;Pregnancy Related | Drug: Prednisone;Drug: Hydroxychloroquine;Drug: CertolizumabPegol injection | Qilu Hospital of Shandong University | NULL | Recruiting | 20 Years | 45 Years | Female | 100 | China | |
7 | ChiCTR2100048802 | 2021-07-1520210715 | 2021-07-1620210716 | A prospective non-randomized controlled study on the treatment of interstitial pneumonia of RA with Peitushengjinjiedutongluo method A prospective non-randomized controlled study on the treatment of interstitial pneumonia of RA with ... | A prospective cohort study on the treatment of interstitial pneumonia of RA with Peitushengjinjiedutongluo method A prospective cohort study on the treatment of interstitial pneumonia of RA with Peitushengjinjiedut ... | Rheumatoid arthritis with interstitial pneumonia | experimental group:Syndrome Differentiation and Flavoring of Peitushengjin Chinese Medicine Granules;control group:Hydroxychloroquine + prednisone; experimental group:Syndrome Differentiation and Flavoring of Peitushengjin Chinese Medicine Granules ... | Zhejiang Chinese Medical University | NULL | Pending | 18 | 65 | Both | experimental group:285;control group:240; | N/A | China |
8 | ITMCTR2100005066 | 2021-07-1520210715 | 2021-07-1620210716 | A prospective non-randomized controlled study on the treatment of interstitial pneumonia of RA with Peitushengjinjiedutongluo method A prospective non-randomized controlled study on the treatment of interstitial pneumonia of RA with ... | A prospective cohort study on the treatment of interstitial pneumonia of RA with Peitushengjinjiedutongluo method A prospective cohort study on the treatment of interstitial pneumonia of RA with Peitushengjinjiedut ... | Rheumatoid arthritis with interstitial pneumonia | control group:Hydroxychloroquine + prednisone;experimental group:Syndrome Differentiation and Flavoring of Peitushengjin Chinese Medicine Granules; control group:Hydroxychloroquine + prednisone;experimental group:Syndrome Differentiation and Flavor ... | Zhejiang Chinese Medical University | NULL | Pending | 18 | 65 | Both | control group:240;experimental group:285; | N/A | China |
9 | EUCTR2020-005096-12-SE (EUCTR) | 31/05/202120210531 | 09/04/202120210409 | Utvärdering av två kortison behandlingsstrategier hos patienter med nydiagnostiserad, tidigare obehandlad ledgångsreumatism: en randomiserad, öppen, non-inferiority klinisk studie Utvärdering av två kortison behandlingsstrategier hos patienter med nydiagnostiserad, tidigare obeha ... | Utvärdering av två kortison behandlingsstrategier hos patienter med nydiagnostiserad, tidigare obehandlad reumatoid artrit: en randomiserad, öppen, non-inferiority klinisk studie Utvärdering av två kortison behandlingsstrategier hos patienter med nydiagnostiserad, tidigare obeha ... | Rheumatoid arthritis MedDRA version: 23.1;Level: PT;Classification code 10039073;Term: Rheumatoid arthritis;System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20] Rheumatoid arthritis MedDRA version: 23.1;Level: PT;Classification code 10039073;Term: Rheumatoid ar ... | Trade Name: Prednisolon Pfizer Product Name: Prednisolon Pfizer INN or Proposed INN: PREDNISOLONE | Karolinska Universitetssjukhuset | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 166 | Phase 4 | Sweden | ||
10 | NCT04117165 (ClinicalTrials.gov) | March 1, 202120210301 | 30/9/201920190930 | Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arthritis Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arth ... | Assessment of the Clinical and Medico-economic Impact of SinnoTest®, a Software That Predicts the Effectiveness of Biotherapy Treatments, in Patients With Rheumatoid Arthritis (RA) Assessment of the Clinical and Medico-economic Impact of SinnoTest®, a Software That Predicts the Ef ... | Arthritis, Rheumatoid;Biological Therapy | Diagnostic Test: Biotherapy Prescription with SinnoTest® software;Drug: Patient Current Care | University Hospital, Grenoble | NULL | Withdrawn | 18 Years | 70 Years | All | 0 | N/A | France |